EIM
AGN

Essex Investment Management’s Allergan Inc AGN Stock Holding History

Essex Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,468
Closed -$2.44M – 371
2014
Q4 		$2.44M Hold
11,468
– – 0.36% 73
2014
Q3 		$2.04M Buy
11,468
+22
+0.2% +$3.65K 0.31% 89
2014
Q2 		$1.94M Buy
11,446
+31
+0.3% +$4.83K 0.29% 113
2014
Q1 		$1.42M Sell
11,415
-1,254
-10% -$153K 0.21% 152
2013
Q4 		$1.41M Sell
12,669
-12
-0.1% -$1.15K 0.2% 151
2013
Q3 		$1.15M Buy
12,681
+663
+6% +$59.5K 0.17% 159
2013
Q2 		$1.01M Buy
+12,018
New +$1.25M 0.18% 151

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Essex Investment Management's AGN Position: Q1 2015 in Review

Essex Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 11,468 shares — an estimated $2.44M sold.

Essex Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.44M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Essex Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Essex Investment Management sold 11,468 Allergan Inc shares in Q1 2015, an estimated $2.44M.
  • Essex Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Essex Investment Management's Allergan Inc position peaked at $2.44M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Essex Investment Management's 13F filing for Q1 2015, filed 6 May 2015.